Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 2790176)

Published in Clin Transl Sci on August 01, 2009

Authors

Chau-Ching Liu1, Amy H Kao, Douglas M Hawkins, Susan Manzi, Abdus Sattar, Nicole Wilson, Joseph M Ahearn

Author Affiliations

1: University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. liu5@pitt.edu

Articles cited by this

The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47

A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73

Systemic lupus erythematosus. N Engl J Med (2008) 10.22

Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum (1996) 3.40

Systemic lupus erythematosus. Lancet (2007) 3.32

Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum (2004) 3.23

Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum (2002) 2.99

Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum (2004) 2.16

Antinuclear antibody testing. A study of clinical utility. Arch Intern Med (1996) 1.64

Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch Intern Med (2004) 1.63

Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol (1998) 1.54

The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (1985) 1.34

Sequential studies of complement activation in systemic lupus erythematosus. Scand J Rheumatol (1985) 1.02

Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum (2006) 1.01

Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum (2005) 0.98

Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future. Curr Rheumatol Rep (2004) 0.95

The value of complement activation products in the assessment of systemic lupus erythematosus flares. Clin Immunol Immunopathol (1995) 0.84

Articles by these authors

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet (2009) 5.75

Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet (2008) 4.33

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum (2013) 4.02

Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum (2005) 3.31

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med (2005) 2.92

Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum (2004) 2.16

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum (2003) 2.11

Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet (2011) 1.92

Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet (2008) 1.80

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum (2010) 1.67

Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol (2007) 1.63

Robust singular value decomposition analysis of microarray data. Proc Natl Acad Sci U S A (2003) 1.58

Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet (2011) 1.57

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum (2007) 1.53

Risk of unintended pregnancy among women with systemic lupus erythematosus. Arthritis Rheum (2008) 1.50

Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun (2013) 1.47

Hyperhomocysteinemia as a risk factor for ischemic heart disease. J Coll Physicians Surg Pak (2004) 1.43

Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum (2008) 1.41

Inferential, robust non-negative matrix factorization analysis of microarray data. Bioinformatics (2006) 1.37

Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum (2004) 1.29

The search for lupus biomarkers. Best Pract Res Clin Rheumatol (2009) 1.26

Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol (2005) 1.17

Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev (2013) 1.14

Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum (2013) 1.12

The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol (2002) 1.10

Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol (2011) 1.04

Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum (2004) 1.03

Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis (2013) 1.03

Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis (2012) 1.02

Update on vascular disease in systemic lupus erythematosus. Curr Opin Rheumatol (2003) 1.02

Biomarkers for systemic lupus erythematosus. Transl Res (2012) 1.01

Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum (2006) 1.01

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum (2004) 1.01

Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet (2004) 1.00

Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum (2005) 0.98

Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus. Arthritis Rheum (2007) 0.97

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol (2010) 0.97

European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus. Arthritis Rheum (2009) 0.96

A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96

Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future. Curr Rheumatol Rep (2004) 0.95

The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum (2007) 0.92

Neogenin and RGMa control neural tube closure and neuroepithelial morphology by regulating cell polarity. J Neurosci (2008) 0.92

Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis. Clin Transl Sci (2011) 0.91

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Res (2012) 0.91

C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol (2008) 0.91

Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory. Pain Med (2003) 0.90

Atherosclerosis risk factors in systemic lupus erythematosus. Curr Rheumatol Rep (2009) 0.90

Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection. AIDS (2016) 0.90

The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr Res (2012) 0.89

Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant (2010) 0.88

Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. Atherosclerosis (2013) 0.88

Association between depression and coronary artery calcification in women with systemic lupus erythematosus. Rheumatology (Oxford) (2009) 0.88

Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88

Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus. Arthritis Rheum (2006) 0.88

Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke (2008) 0.88

Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res (2008) 0.88

Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol (2007) 0.87

Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus. Am J Cardiol (2013) 0.87

Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity. Ann Hum Genet (2007) 0.87

Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Best Pract Res Clin Rheumatol (2009) 0.87

Quantitative evaluations of ankle spasticity and stiffness in neurological disorders using manual spasticity evaluator. J Rehabil Res Dev (2011) 0.86

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis (2012) 0.86

Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. BMC Med Genet (2011) 0.85

A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care Res (Hoboken) (2011) 0.85

Relative contributions of age and atherosclerosis to vascular stiffness. Clin Transl Sci (2008) 0.85

Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health (Larchmt) (2009) 0.85

Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis. J Rheumatol (2005) 0.85

Association between depression and vascular disease in systemic lupus erythematosus. J Rheumatol (2011) 0.85

Apoptosis and autoimmunity. Immunol Res (2006) 0.85

Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res (Hoboken) (2010) 0.85

Frequency of growth hormone deficiency in short statured children. J Coll Physicians Surg Pak (2005) 0.84

Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology (2013) 0.83

Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes. J Rheumatol (2009) 0.83